Why Is BioCryst Pharmaceuticals Stock Trading Lower Today?

Benzinga
2025.10.14 17:07
portai
I'm PortAI, I can summarize articles.

BioCryst Pharmaceuticals, Inc. ( NASDAQ:BCRX ) on Tuesday agreed to acquire Astria Therapeutics, Inc. ( NASDAQ:ATXS ) for a mix of cash and stock. The deal represents an implied value of $13 per Astria share, and approximately $700 million in enterprise value.

Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.